Author

Benjamin Schwartz

GlaxoSmithKline (United States)ORCID 0009-0007-1661-9368Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Anastasia Kavasakali· 1 shared Andrea BertottiiD· 1 shared Angham Al SaediiD· 1 shared Brian T. JonesiD· 1 shared Camille FourneauxiD· 1 shared Cansu DinçeriD· 1 shared Cuthbert D. Martyr· 1 shared Diana Marcela Muñoz· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anastasia Kavasakali

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintDec 27, 2025

On-target mutations confer resistance to WRN helicase inhibitors in Microsatellite Unstable Cancer Cells.

Gabriele Picco, Yanhua Rao, Angham Al Saedi…·Mathew J. Garnett

This study identifies on-target WRN mutations as resistance mechanisms in MSI cancer cells to WRN helicase inhibitors and suggests combination therapies to prevent resistance.

3 citations

humanwhole-exome sequencing

𝕏 PostBluesky